Defence technology transfers to civilian life by having development potential as a rapid medical test
This article was originally published in Clinica
Technology developed by the US Navy to rapidly detect anthrax and other biological weapons in the air could soon be in use in hospitals and non-clinical settings as a non-invasive, on-site test for heart attacks and other medical conditions, as well as for drugs of abuse.
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”